Seroprevalence and force of infection of varicella-zoster virus in Luxembourg

Epidemiology and Infection

Volumn 132, Issue 6, 2004, Pages 1121-1127

  Mossong, Joel ^a,b   Putz, L ^a,b   Schneider, F ^a  

^a LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^b LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ADULTHOOD; AGE; ARTICLE; BLOOD ANALYSIS; CHICKENPOX; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH SURVEY; HIGH SCHOOL; HOSPITAL ADMISSION; HUMAN; LUXEMBOURG; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIMARY SCHOOL; SEROLOGY; SEROPREVALENCE; VARICELLA ZOSTER VIRUS; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHICKENPOX; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPESVIRUS 3, HUMAN; HUMANS; INFANT; INFANT, NEWBORN; LUXEMBOURG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES;

EID: 10444258020     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268804002754     Document Type: Article

References (27)

1. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965; 58: 9-20.
2. Gershon AA, Takahashi M, White CJ. Varicella vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. Philadelphia: Saunders, 1999: 475-507.
3. Wise RP, Salive ME, Braun MM, et al. Postlicensure safety surveillance for varicella vaccine. J Am Med Assoc 2000; 284: 1271-1279.
4. Brisson M, Edmunds WJ, Law B, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001; 127: 305-314.
5. Galil K, Lee B, Strine T, et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 2002; 347: 1909-1915.
6. Thiry N, Beutels P, Shkedy Z, et al. The sero-epidemiology of primary varicella-zoster virus infection in Flanders (Belgium). Eur J Pediatr 2002; 161: 588-593.
7. Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002; 20: 2500-2507.
8. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 2002; 360: 678-682.
9. Edmunds WJ, Brisson M, Gay NJ, Miller E. Varicella vaccination: a double-edged sword? Commun Dis Public Health 2002; 5 185-186.
10. Mossong J, Putz L, Schneider F. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Epidemiol Infect 2004; 132: 11-18.
11. Edmunds WJ, Pebody RG, Aggerback H, et al. The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect 2000; 125: 113-125.
12. Annuaire statistique, [Statistical Yearbook]. Service central de la statistique et des études économiques. Luxembourg, 2003.
13. Royston P, Altman D. Approximating statistical functions by using fractional polynomial regression. The Statistician 1997; 46: 411-422.
14. Remme J, Mandara MP, Leeuwenburg J. The force of measles infection in East Africa. Int J Epidemiol 1984; 13: 332-339.
15. Gershon AA, Raker R, Steinberg S, Topf-Olstein B, Drusin LM. Antibody to Varicella-Zoster virus in parturient women and their offspring during the first year of life. Pediatrics 1976; 58: 692-696.
16. Griffiths DA. A catalytic model of infection for measles. Appl Statist 1974; 23: 330-339.
17. McCullagh P, Nelder JA. Generalized linear models, 2nd edn. Monograph on statistics and applied probability, 1989. New York: Chapman & Hall.
18. de Melker HE, Nagelkerde NJ, Conyn-van Spaendonck MA. Non-participation in a population-based seroprevalence study of vaccine-preventable diseases. Epidemiol Infect 2000; 124: 255-262.
19. Aebi C, Fischer K, Gorgievski M, Matter L, Muhlemann K. Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data. Vaccine 2001; 19: 3097-3103.
20. Wutzler P, Farber I, Wagenpfeil S, Bisanz H, Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine 2001; 20: 121-124.
21. Gabutti G, Penna C, Rossi M, et al. The seroepidemiology of varicella in Italy. Epidemiol Infect 2001; 126: 433-440.
22. Les chiffres clés de l'Education Nationale. Statistiques et indicateurs 2001-2002 [Key figures of national education. Statistics and indicators 2001-2002]. SCRIPT. Ministère de l'Education Nationale, de la Formation Professionnelle et des Sports. Luxembourg, 2003.
23. Gidding HF, MacIntyre CR, Burgess MA, Gilbert GL. The seroepidemiology and transmission dynamics of varicella in Australia. Epidemiol Infect 2003; 131: 1085-1089.
24. Bramley JC, Jones IG. Epidemiology of chickenpox in Scotland: 1981 to 1998. Commun Dis Public Health 2000; 3: 282-287.
25. Ross AM, Fleming DM. Chickenpox increasingly affects preschool children. Commun Dis Public Health 2000; 3: 213-215.
26. Panagiotopoulos T, Antoniadou I, Valassi-Adam E. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. Br Med J 1999; 319: 1462-1467.
27. Edmunds WJ, Brisson M. The effect of vaccination on the epidemiology of varicella zoster virus. J Infect 2002; 44: 211-219.